Xerostomia Therapeutics Market - Global Industry Analysis, Growth, Trends, and Forecast | Growth Market Reports

The global xerostomia therapeutics market size is anticipated to register a high CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the increasing demand for chemotherapy and radiotherapy in cancer treatment market.

Xerostomia is a dry mouth condition and is commonly caused due to absent of salivary flow producing mucosal dryness. The rise in chemotherapy and radiation therapy is expected to lead to an increased incidences of xerostomia. Adoption of radiation and chemotherapy to undergo for the cancer treatment is likely to damage the salivary gland and develop effects such as dryness in mouth. Every year, about 640,000 cancer patients receive chemotherapy treatment that are mainly prescribed by medical practitioners, according to the Centers for Disease Control & Prevention (CDC). It was estimated that over 3.4 million women suffered from breast cancer in the U.S. in January 1, 2016, as per a report published by American Cancer Society. Around 48% of the women with stage IV breast cancer are most likely to receive chemotherapy or radiation.

Get Exclusive Sample Report at: https://growthmarketreports.com/request-sample/2215

Products including saliva substitute gels, lozenges, toothpastes, oral-adhering discs, sugar-free chewing gums patches, mouthwashes & oral rinses, and melts are some of the key medications available in the market. However, the prices of these products range from USD 10 to 90 and yet there are favorable remuneration policies of these products across several countries. For instance, funds are provided to patients with radiation-induced xerostomia undergoing treatment with drug under the Exceptional Access Program by Ontario Ministry of Health and Long-Term Care.

Market Trends, Drivers, Restraints, and Opportunities

• Increasing acceptance of radiotherapy and chemotherapy in cancer treatment with increasing use of prescribed medications are some of the key factors expected to fuel the market growth.
• Easy available and cost-effective medications are some of the key drivers of the market.
• Favorable government policies such as easy accessibility to reimbursement policies and other favorable policies of the patients are expected to accelerate the market expansion.
• Certain advantages such as safety & efficacy, availability of limited branded drugs, wide variety & availability, and low pricing of products are other key drivers of the market growth.

Market Segment Insights

Over the counter segment is expected to grow at a rapid pace

Based on types, the global xerostomia therapeutics market is divided into over the counter (OTC) and prescription. The OTC segment is expected to grow at a rapid pace in the coming years owing to safety & efficacy, wide variety & availability, and low pricing of products of OTC drugs. However, the prescription segment is anticipated to accounts for a key share of the market during the forecast period due to the adoption by large number of medical practitioners.

Dentifrices segment is projected to expand at a considerable CAGR

On the basis of products, the market is divided into salivary stimulants, dentifrices, and salivary substitutes. The dentifrices segment is projected to expand at a considerable CAGR during the projected period due to its easy availability, effectiveness, affordability, and higher adoption among end users. Meanwhile, the salivary stimulants segment is anticipated to grow at a substantial rate during the forecast period owing to wide range of products and substitutes along with easy availability.

For Any Questions On This Report: https://growthmarketreports.com/enquiry-before-buying/2215

Regional Outlook

In terms of regions, the global xerostomia therapeutics market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market of the North America is anticipated to constitute a key market share during the targeted years owing to increasing incidences of xerostomia and increasing dry mouth awareness initiatives in the region. The market of Asia Pacific, however, is anticipated to expand at a robust growth rate during the forecast period due to growing healthcare expenditure and various growing initiatives by governments across the region.

Competitive Landscape

Key players competing in the global xerostomia therapeutics market are Church & Dwight Co., Inc.; GlaxoSmithKline Plc; Hikma Pharmaceuticals Plc; Pendopharm, Inc; Sun Pharmaceuticals Industries Ltd.; Pfizer, Inc.; Parnell Pharmaceuticals, Inc.; Lupin Pharmaceuticals, Inc.; Colgate-Palmolive Company; OraCoat; and Acacia Pharma Ltd. The main market players are continuously engaged in the activities such as mergers, acquisitions, research and developments, investments for innovative products, and collaborations. For instance, a major oral care company, Hikma Pharmaceuticals acquired Roxane Laboratories, a part of West-Ward Pharmaceuticals Corp in April 2017 to enhance the product portfolio.

About Growth Market Reports:

GMR provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Industry Intelligence Solutions”. GMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. Our key analysis segments, though not restricted to the same, include market entry strategies, market size estimations, market trend analysis, market opportunity analysis, market threat analysis, market growth/fall forecasting, primary interviews, secondary research & consumer surveys.

Contact:

Growth Market Reports

Phone: +1 909 414 1393

Email: [email protected]

Web: https://growthmarketreports.com

Follow Us: LinkedIn | Twitter